Neurotrophic factor delivery by encapsulated cell grafts

Isao Date, Tetsuro Shingo, Takashi Ohmoto

Research output: Contribution to journalArticle

Abstract

One of the objectives of neural transplantation for neurological disorders is to deliver neurotransmitters or neurotrophic factors into the host brain. Neurotrophic factor delivery is considered more ideal because neuronal circuit reconstruction of the host can be expected by this method. In order to deliver neurotrophic factors into the brain, three approaches have been studied: direct injection of neurotrophic factors by using osmotic pump, induction of genes of neurotrophic factors into the host brain (in vivo gene therapy), and grafting of encapsulated neurotrophic factor-secreting cells into the brain (ex vivo gene therapy). Due to the development of molecular biology techniques, many types of neurotrophic factor-secreting cells have been created and these cells can be used for the treatment of certain neurological disorders such as Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis (ALS), and cerebral ischemia. Encapsulated cell grafting procedure is very useful for using these cells because immunological reaction of the host brain and tumorigenesis of donor cells can be prevented by this procedure. In this review, neurotrophic factor-secreting cell grafting into the brain is summarized.

Original languageEnglish
Pages (from-to)247-251
Number of pages5
JournalInternational Congress Series
Volume1252
Issue numberC
DOIs
Publication statusPublished - Jun 1 2003

Fingerprint

Nerve Growth Factors
Transplants
Brain
Nervous System Diseases
Genetic Therapy
Amyotrophic Lateral Sclerosis
Brain Ischemia
Neurotransmitter Agents
Parkinson Disease
Molecular Biology
Alzheimer Disease
Carcinogenesis
Transplantation
Injections
Genes

Keywords

  • Cerebral ischemia
  • Encapsulated cell grafting
  • Neural transplantation
  • Neurotrophic factor

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Neurotrophic factor delivery by encapsulated cell grafts. / Date, Isao; Shingo, Tetsuro; Ohmoto, Takashi.

In: International Congress Series, Vol. 1252, No. C, 01.06.2003, p. 247-251.

Research output: Contribution to journalArticle

Date, Isao ; Shingo, Tetsuro ; Ohmoto, Takashi. / Neurotrophic factor delivery by encapsulated cell grafts. In: International Congress Series. 2003 ; Vol. 1252, No. C. pp. 247-251.
@article{7294ac4bf8b74a3b84a3cb66a32c9dc4,
title = "Neurotrophic factor delivery by encapsulated cell grafts",
abstract = "One of the objectives of neural transplantation for neurological disorders is to deliver neurotransmitters or neurotrophic factors into the host brain. Neurotrophic factor delivery is considered more ideal because neuronal circuit reconstruction of the host can be expected by this method. In order to deliver neurotrophic factors into the brain, three approaches have been studied: direct injection of neurotrophic factors by using osmotic pump, induction of genes of neurotrophic factors into the host brain (in vivo gene therapy), and grafting of encapsulated neurotrophic factor-secreting cells into the brain (ex vivo gene therapy). Due to the development of molecular biology techniques, many types of neurotrophic factor-secreting cells have been created and these cells can be used for the treatment of certain neurological disorders such as Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis (ALS), and cerebral ischemia. Encapsulated cell grafting procedure is very useful for using these cells because immunological reaction of the host brain and tumorigenesis of donor cells can be prevented by this procedure. In this review, neurotrophic factor-secreting cell grafting into the brain is summarized.",
keywords = "Cerebral ischemia, Encapsulated cell grafting, Neural transplantation, Neurotrophic factor",
author = "Isao Date and Tetsuro Shingo and Takashi Ohmoto",
year = "2003",
month = "6",
day = "1",
doi = "10.1016/S0531-5131(03)00010-4",
language = "English",
volume = "1252",
pages = "247--251",
journal = "International Congress Series",
issn = "0531-5131",
publisher = "Elsevier BV",
number = "C",

}

TY - JOUR

T1 - Neurotrophic factor delivery by encapsulated cell grafts

AU - Date, Isao

AU - Shingo, Tetsuro

AU - Ohmoto, Takashi

PY - 2003/6/1

Y1 - 2003/6/1

N2 - One of the objectives of neural transplantation for neurological disorders is to deliver neurotransmitters or neurotrophic factors into the host brain. Neurotrophic factor delivery is considered more ideal because neuronal circuit reconstruction of the host can be expected by this method. In order to deliver neurotrophic factors into the brain, three approaches have been studied: direct injection of neurotrophic factors by using osmotic pump, induction of genes of neurotrophic factors into the host brain (in vivo gene therapy), and grafting of encapsulated neurotrophic factor-secreting cells into the brain (ex vivo gene therapy). Due to the development of molecular biology techniques, many types of neurotrophic factor-secreting cells have been created and these cells can be used for the treatment of certain neurological disorders such as Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis (ALS), and cerebral ischemia. Encapsulated cell grafting procedure is very useful for using these cells because immunological reaction of the host brain and tumorigenesis of donor cells can be prevented by this procedure. In this review, neurotrophic factor-secreting cell grafting into the brain is summarized.

AB - One of the objectives of neural transplantation for neurological disorders is to deliver neurotransmitters or neurotrophic factors into the host brain. Neurotrophic factor delivery is considered more ideal because neuronal circuit reconstruction of the host can be expected by this method. In order to deliver neurotrophic factors into the brain, three approaches have been studied: direct injection of neurotrophic factors by using osmotic pump, induction of genes of neurotrophic factors into the host brain (in vivo gene therapy), and grafting of encapsulated neurotrophic factor-secreting cells into the brain (ex vivo gene therapy). Due to the development of molecular biology techniques, many types of neurotrophic factor-secreting cells have been created and these cells can be used for the treatment of certain neurological disorders such as Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis (ALS), and cerebral ischemia. Encapsulated cell grafting procedure is very useful for using these cells because immunological reaction of the host brain and tumorigenesis of donor cells can be prevented by this procedure. In this review, neurotrophic factor-secreting cell grafting into the brain is summarized.

KW - Cerebral ischemia

KW - Encapsulated cell grafting

KW - Neural transplantation

KW - Neurotrophic factor

UR - http://www.scopus.com/inward/record.url?scp=85023075901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85023075901&partnerID=8YFLogxK

U2 - 10.1016/S0531-5131(03)00010-4

DO - 10.1016/S0531-5131(03)00010-4

M3 - Article

AN - SCOPUS:85023075901

VL - 1252

SP - 247

EP - 251

JO - International Congress Series

JF - International Congress Series

SN - 0531-5131

IS - C

ER -